The DSB has been designated as the sole service provider for the future Unique Product Identifier (UPI) System performing the function of issuer of UPI codes as well as operator of the UPI reference data library.
The DSB expects to be providing UPIs for over-the-counter (OTC) derivatives to enable global regulatory authorities to aggregate data on OTC derivatives transactions to help assess systemic risk.
The UPI Service is expected to launch in 2023 dependent on confirmation of the first major regulatory reporting mandate. Please view the UPI Timeline here.
What is a UPI
UPI stands for ‘Unique Product Identifier’ and is designed to facilitate effective aggregation of over-the-counter (OTC) derivatives transaction reports on a global basis.
In the first instance, the role of the UPI is to uniquely identify the product involved in an OTC derivatives transaction that an authority requires, or may require in the future, to be reported to a Trade Repository (TR). The UPI will work in conjunction with Unique Transaction Identifiers (UTIs) and Critical Data Elements (CDE) which are also expected to be reportable to global regulatory authorities.
The Committee on Payments and Market Infrastructures (CPMI) and the International Organization of Securities Commissions (IOSCO) published their finalised UPI Technical Guidance in September 2017. Under the Technical Guidance, a unique UPI code would be assigned to each distinct OTC derivative product and would map to reference data elements with specific values that together describe the product. The collection of reference data elements and their values for each product would reside in a UPI Reference Data Library to be administered by the UPI Service Provider.
In addition, the DSB is committed to open consultation with market participants in determining the key principles underpinning the UPI service. The timeline for the consultation in 2021 is available here, and more information about the consultation itself is available here.
The DSB will continue to provide updates to the market as more information becomes available. Industry participants with queries are encouraged to subscribe to UPI updates via the link on this page, or contact the team at email@example.com.
First published on Thomson Reuters Regulatory Intelligence on 20th October 2022. EMIR Refit leads the global drive for OTC derivatives standardisation […]
The Derivatives Service Bureau participated in the “Unlocking the potential of machine-readable and executable reporting (MRER)” workshop hosted by FISMA/ESMA on […]
DSB welcomes EMIR Refit Publication: UPI mandate now in EU law DSB assists stakeholders for UPI implementation London, 11 Oct […]